butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may decrease sufentanil ranges and efficacy, potentially precipitating withdrawal syndrome in patients that have designed physical dependence to sufentanil. Discontinuat